Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla

BSE1424.755.2 (+0.37 %)

PREV CLOSE ( ) 1419.55

OPEN PRICE ( ) 1423.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 32752

TODAY'S LOW / HIGH ( )1416.40 1434.20

52 WK LOW / HIGH ( )897.7 1519

NSE1424.754.7 (+0.33 %)

PREV CLOSE( ) 1420.05

OPEN PRICE ( ) 1428.00

BID PRICE (QTY) 1424.75 (42)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 804513

TODAY'S LOW / HIGH( ) 1415.20 1434.00

52 WK LOW / HIGH ( )896.85 1519

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935

Management Info

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000

Email contactus@cipla.com

Website www.cipla.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg, MCX

NEWS

30Apr Cipla gains as its arm acquires busine
Cipla is currently trading at Rs. 1411.40, up by 3.85 points or 0.27% fr..

29Apr Cipla's arm acquires business undertak
Cipla Health (CHL), the wholly owned subsidiary of Cipla has completed t..

18Apr Announcement under Regulation 30 (LOD
In compliance with the provisions of Regulation 30 (Listing Obligations..

16Apr Cipla, Deep Industries and Bharti Airt
Cipla Health (CHL), the wholly owned subsidiary and consumer healthcare..

16Apr Cipla's arm signs agreement for acquis
Cipla Health (CHL), the wholly owned subsidiary and consumer healthcare..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	11141.4	25134.7
Gross Profit	13807.6	34405.4
Operating Profit	15248.4	42493.7
Net Sales	43813.3	157906

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE) 4899.45 (2.36%)	M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Torrent Pharma (BSE) 2732.60 (2.20%)	M.Cap ( in Cr)92483.60

Shareholding Pattern

	PROMOTERS	33.47%
	MUTUAL FUNDS/UTI	16.83%
	NON-INSTITUTION	16.36%
	FI/BANKS/INSURANCE	5.49%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Nifty Pha...	12.04
Nippon India Nifty ...	12.03
ICICI Pru Nifty Hea...	10.55
Axis NIFTY Healthcare ETF	10.54
Aditya Birla SL Nif...	10.53
Mirae Asset Healthc...	9.62
Aditya Birla SL Pha...	8.31

Risk Disclosures on Derivatives

Smart Quotes

CIPLA LTD.